(WXYZ) — A new drug has been approved by the Food and Drug Administration to treat moderate-to-severe Crohn's disease. It’s called Rinvoq, a pill that adults can ...

The inflammatory bowel disorder Crohn’s disease can be treated by several different biologic drugs administered as injections or infusions. The FDA just approved the first daily pill for the chronic ...

– The co-primary endpoints of endoscopic response (visible reduction of intestinal lining damage) and clinical remission were achieved by significantly more patients treated with RINVOQ (upadacitinib) ...

(RTTNews) - The U.S. Food and Drug Administration approved AbbVie's (ABBV) Rinvoq or upadacitinib for the treatment of adults with moderately to severely active Crohn's disease who have had an ...